Back to mobile site

Needham & Company Reiterates Buy on HealthStream (HSTM) Following 4Q

February 23, 2017 7:03 AM EST Send to a Friend
Needham & Company reiterated a Buy rating and $28.00 price target on HealthStream (NASDAQ: HSTM) following the company's 4Q earnings ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login